A Case of Paroxetine-Related Hyperprolactinemia.
- Author:
Dae Up BAEK
1
;
Mi Ae CHO
;
Young Myo JAE
Author Information
1. Department of Psychiatry, Dongnae Bongseng Hospital, Busan, Korea.
- Publication Type:Case Report
- Keywords:
Paroxetine;
Selective serotonin reuptake inhibitor;
Hyperprolactinemia;
Galactorrhea
- MeSH:
Adult;
Bromocriptine;
Cyclohexanols;
Depression;
Dopamine Agonists;
Female;
Galactorrhea;
Humans;
Hyperprolactinemia;
Paroxetine;
Pregnancy;
Prescriptions;
Serotonin Uptake Inhibitors;
Venlafaxine Hydrochloride
- From:Korean Journal of Psychopharmacology
2010;21(2):99-103
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Although selective serotonin reuptake inhibitors (SSRIs) have been widely used in both psychiatry and other medicine, few cases have been reported SSRI-related hyperprolactinemia and/or galactorrhea. We experienced one case which showed both galactorrhea and hyperprolactinemia following treatment with paroxetine. In the case, a 37-year-old multiparous woman reported galactorrhea after 8-weeks paroxetine treatment for her depression. After 1 month prescription of bromocriptine, dopamine agonist, as well as switching medication from paroxetine to venlafaxine, serotonin-norepinephrine reuptake inhibitor, both galactorrhea and hyperprolactinemia were disappeared. Both hyperprolactinemia and galactorrhea have not been observed even after the cessation of bromocriptine prescription.
